Market Place
Sourcing Support
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Aurobindo`s Generic Ranolazine Receives Approval in the U.S.
23 Dec 2022 //
FDA
VKT Pharma`s Generic Ranolazine Receives Approval in the U.S.
19 Jan 2022 //
FDA
Amneal`s Generic Ranolazine Receives Approval In US
16 Mar 2021 //
FDA
Graviti Pharm`s Generic Choline Ranolazine Receives Approval in US
30 Jan 2021 //
FDA
KYE Pharmaceuticals Announces Approval of CORZYNA™ in Canada
05 Jan 2021 //
NEWSWIRE
Sunshine Lake Generic Ranolazine Receives Approval in US
26 Mar 2020 //
FDA
Sungen Pharma`s generic Ranolazine Receives Approval in US
26 Mar 2020 //
FDA
Micro Lab`s Generic Ranolazine Receives Approval in US
29 Feb 2020 //
FDA
Mankind Pharma`s Generic Ranolazine Receives Approval in US
15 Feb 2020 //
FDA
Amerigen pharma`s Generic Ranolazine Receives Approval in US
30 Oct 2019 //
FDA
Glenmark receives final nod from USFDA for drug to treat chronic angina
16 Jul 2019 //
BUSINESS STANDARD
GLENMARK PHARMS LTD`s generic RANOLAZINE Receives Approval in US
05 Jul 2019 //
FDA
Sciegen Pharms` Generic Ranolazine Receives Approval In US
04 Jun 2019 //
Teva shares hit 19-year low after opioid settlement, analyst downgrades
31 May 2019 //
FIERCE PHARMA
Ajanta Pharma`s Generic Ranolazine Receives Approval in US
31 May 2019 //
FDA
Cipla`s Generic Ranolazine Receives Approval in US
31 May 2019 //
FDA
Sun Pharms Generic Ranolazine Receives Approval in US
31 May 2019 //
FDA
Actavis Generic Ranolazine Receives Approval in US
30 May 2019 //
FDA
Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) U.S
28 May 2019 //
BUSINESSWIE
Cipla`s Generic Ranolazine Receives Tentative Approval in US
31 Oct 2018 //
FDA
Drugmakers Cancel Price Hikes After California Law Takes Effect
12 Jul 2018 //
BLOOMBERG
Aurobindo Pharma’s Generic Ranolazine Receives Approval In US
05 Dec 2017 //
FDA
Gilead sells phase 2 addiction drug to ex-CVT team
17 Feb 2017 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.